posting velocity //
Opens vs closes per day
Based on 3 events over 3 days. Green days had more opens than closes, red vice-versa. The dark line is the 7-day rolling average.
Posting timing (day/hour) is available only when there are at least 5 jobs with a real publish stamp spread across 3 distinct days. This company's source doesn't expose post times, or there isn't enough data yet — showing what we know for sure: how many jobs are open, in which domains, and at which seniority levels.
Showing: Israel. Click another pill to switch.
Open now
3
Total active openings across all sites
Δ 28-day
+3
Opens minus closes in the last 28 days
Δ 90-day
+3
Opens minus closes in the last 90 days
posting velocity //
Based on 3 events over 3 days. Green days had more opens than closes, red vice-versa. The dark line is the 7-day rolling average.
role mix //
The green layer is the current share of active openings by role. The grey dashed layer is the 90-day baseline — gaps between them show where the company is shifting its hiring mix.
seniority pyramid //
Distribution of active openings by seniority. The 'unknown' row groups jobs from sources that don't expose seniority.
geography //
Active openings by region. Click a row to see jobs in that area.
time on market //
Median
Soon
25th pct
Soon
75th pct
Soon
Based on 0 closed jobs and 3 still open (right-censored). Curve is Kaplan-Meier; band is the 95% CI.Still collecting — median tracking age is ~1.5 days (need 14+). 0% of closures were within 3 days, which often reflects feed churn rather than hires.
Window: 180 days back. Don't read the mean — the long tail biases it. Median and percentiles are the honest summary.
Republish rate
—
Fewer than 10 closures in the window — not enough to compute.
company intel · ai-generated
Updated 1d ago
Edwards Lifesciences is a publicly traded American medical-device company specializing in cardiovascular technologies, particularly transcatheter heart valves and hemodynamic monitoring systems. It trades on the NYSE under the ticker EW, and is headquartered in Irvine, California.
The company's primary product line is transcatheter aortic valve replacement (TAVR) under the SAPIEN brand, designed for patients with severe aortic stenosis who are not candidates for open-heart surgery. Edwards also produces hemodynamic monitoring platforms including ClearSight and EV1000. Its customers are hospitals, interventional cardiologists, and cardiac surgeons.
Detailed public information about a dedicated R&D center or significant local engineering presence for Edwards Lifesciences in Israel is limited and not something I can confirm with confidence.
key people
Key people for this company are being prepared — they will appear here as soon as available.
hiring signal · from our data
From our job data · always current
3 open roles in Israel
Live openings we track — Israel first, plus worldwide when we have them.
Top roles
news feed
No recent news about this company.